We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-12.93%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$102B
AUM Growth
-$16.3B
Cap. Flow
+$749M
Cap. Flow %
0.73%
Top 10 Hldgs %
23.72%
Holding
4,322
New
210
Increased
1,790
Reduced
1,850
Closed
304
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CYTK icon
2776
Cytokinetics
CYTK
$10.5B
$616K ﹤0.01%
15,681
+360
+2% +$14.5K
GVIP icon
2777
Goldman Sachs Hedge Industry VIP ETF
GVIP
$584M
$616K ﹤0.01%
8,782
-28,812
-77% -$2.28M
CSM icon
2778
ProShares Large Cap Core Plus
CSM
$537M
$615K ﹤0.01%
13,778
-900
-6% -$44.2K
PMT
2779
PennyMac Mortgage Investment
PMT
$827M
$615K ﹤0.01%
44,487
+3,738
+9% +$57.1K
PSCF icon
2780
Invesco S&P SmallCap Financials ETF
PSCF
$27.7M
$614K ﹤0.01%
12,705
-43,332
-77% -$2.27M
EQAL icon
2781
Invesco Russell 1000 Equal Weight ETF
EQAL
$849M
$613K ﹤0.01%
15,616
-2,100
-12% -$90.4K
FLTR icon
2782
VanEck IG Floating Rate ETF
FLTR
$3.04B
$613K ﹤0.01%
+24,848
New +$620K
NUS icon
2783
Nu Skin
NUS
$236M
$613K ﹤0.01%
14,152
+826
+6% +$37.9K
SILK
2784
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$613K ﹤0.01%
16,851
-821
-5% -$29.8K
HE icon
2785
Hawaiian Electric Industries
HE
$2.06B
$611K ﹤0.01%
14,931
-370
-2% -$15.6K
EVOP
2786
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
$610K ﹤0.01%
25,951
-115
-0.4% -$2.62K
TEN
2787
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
$610K ﹤0.01%
35,546
+2,285
+7% +$38.6K
SIG icon
2788
Signet Jewelers
SIG
$3.59B
$609K ﹤0.01%
11,383
+865
+8% +$56.4K
MODV
2789
DELISTED
ModivCare
MODV
$608K ﹤0.01%
7,198
+475
+7% +$48K
UAN icon
2790
CVR Partners
UAN
$1.26B
$608K ﹤0.01%
+6,088
New +$818K
GKOS icon
2791
Glaukos
GKOS
$11.2B
$606K ﹤0.01%
13,349
-2,912
-18% -$138K
ANDE icon
2792
Andersons Inc
ANDE
$2.21B
$603K ﹤0.01%
18,290
+8,037
+78% +$342K
GSEW icon
2793
Goldman Sachs Equal Weight US Large Cap Equity ETF
GSEW
$2.07B
$603K ﹤0.01%
10,862
AADR icon
2794
AdvisorShares Dorsey Wright ADR ETF
AADR
$39.1M
$602K ﹤0.01%
12,395
-387
-3% -$21.1K
PBF icon
2795
PBF Energy
PBF
$8.81B
$602K ﹤0.01%
20,758
+11,555
+126% +$361K
SUSC icon
2796
iShares ESG Aware USD Corporate Bond ETF
SUSC
$1.29B
$602K ﹤0.01%
26,008
-1,168
-4% -$27.7K
NWBI icon
2797
Northwest Bancshares
NWBI
$2.31B
$601K ﹤0.01%
46,948
-3,714
-7% -$47.3K
XMVM icon
2798
Invesco S&P MidCap Value with Momentum ETF
XMVM
$511M
$600K ﹤0.01%
15,263
-9,387
-38% -$414K
SXI icon
2799
Standex International
SXI
$4B
$599K ﹤0.01%
7,060
+1,003
+17% +$93.9K
NMAI icon
2800
Nuveen Multi-Asset Income Fund
NMAI
$497M
$598K ﹤0.01%
45,330
-32,869
-42% -$479K

Similar funds

Raymond James & Associates's Q2 2022 Portfolio in Review

As of Q2 2022, Raymond James & Associates held 4,322 positions worth $102B, down 14% from $119B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q2 2022 filing shows 210 new, 1,790 increased, 1,850 reduced and 304 closed positions. Its largest new stake was Aspen Technology Inc: 54,037 shares worth $9.93M. The largest sale was iShares Core MSCI EAFE ETF, an estimated $551M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q2 2022 buy was Aspen Technology Inc: 54,037 shares worth $9.93M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q2 2022, an estimated $471M increase.
  • Raymond James & Associates's biggest Q2 2022 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $551M.
  • Raymond James & Associates fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $21.5M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $102B portfolio in Q2 2022.
  • Raymond James & Associates opened 210 new positions and closed 304 in Q2 2022.
  • Raymond James & Associates's portfolio value fell 14% quarter-over-quarter to $102B.

Based on Raymond James & Associates's 13F filing for Q2 2022, filed 12 Aug 2022.